We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Optimized Pooled Testing Approach Could Transform Public Health Screening for Infectious Diseases

By LabMedica International staff writers
Posted on 13 Dec 2024
Print article
Image: The new study highlights efficiency in detecting infectious diseases (Photo courtesy of Adobe Stock)
Image: The new study highlights efficiency in detecting infectious diseases (Photo courtesy of Adobe Stock)

Traditional individual testing methods can be resource-intensive, particularly when it comes to large-scale screenings. Pooled testing, on the other hand, enables the testing of multiple specimens together, which reduces both cost and time. This approach has been particularly useful in situations where disease prevalence is low, such as during early screenings or when monitoring for diseases like HIV and chlamydia. In an effort to accelerate and make large-scale disease testing more affordable, researchers have now created an optimized method for pooled testing, which has the potential to revolutionize public health screening for infectious diseases.

A study conducted by researchers at the University of Louisiana at Lafayette (Lafayette, LA, USA) examined the benefits of using pooled testing for detecting infectious diseases, particularly in cases of low prevalence. The team developed a framework to determine the most effective pool size for different infectious diseases, balancing both cost and testing efficiency. Their research utilized data on diseases like HIV, gonorrhea, chlamydia, and SARS-CoV-2.

The researchers found that by strategically pooling specimens, testing costs could be significantly reduced without sacrificing accuracy—an important discovery as health systems face increasing demand for screening across various diseases, including HIV, gonorrhea, and COVID-19. Their findings, published in the Journal of Agricultural, Biological, and Environmental Statistics, revealed that by adjusting pool sizes according to specific infection prevalence rates, public health agencies could realize considerable cost savings while still ensuring accurate prevalence estimates. The software tools developed in this study are now available for download, providing valuable resources for public health officials and researchers worldwide.

“Our findings suggest that careful design and optimization of pooled testing can yield substantial benefits for disease surveillance efforts, particularly in resource-limited settings,” said Dr. Md S. Warasi, Assistant Professor of Mathematics and Statistics at Radford University. “The study provides a new software package and a user-friendly software application to aid health departments and researchers in implementing these optimized testing protocols.”

“The ability to efficiently detect and monitor infectious diseases is crucial for timely interventions. By refining how pooled testing is conducted, we hope to empower health departments worldwide to improve their screening processes and respond faster to potential outbreaks,” added Dr. Kumer P. Das, Assistant Vice President for Research and Innovation at theUniversity of Louisiana at Lafayette.

 

New
Gold Member
Chagas Disease Test
CHAGAS Cassette
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.